Comparison of two recombinant erythropoietin formulations in patients with anemia due to end-stage renal disease on hemodialysis: A parallel, randomized, double blind study

BACKGROUND: Recombinant human erythropoietin (EPO) is used for the treatment of last stage renal anemia. A new EPO preparation was obtained in Cuba in order to make this treatment fully nationally available. The aim of this study was to compare the pharmacokinetic, pharmacodynamic and safety propert...

Descripción completa

Detalles Bibliográficos
Autores principales: Pérez-Oliva, Jorge F, Casanova-González, Martha, García-García, Idrian, Porrero-Martín, Pedro J, Valenzuela-Silva, Carmen M, Hernández-Montero, Tairí, Lagarde-Ampudia, Marcia, Casanova-Kutsareva, Yuri, Ávila-Albuerne, Yisel, Vargas-Batista, Alicia, Bobillo-López, Hailen, Herrera-Valdés, Raúl, López-Saura, Pedro A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1164417/
https://www.ncbi.nlm.nih.gov/pubmed/15910687
http://dx.doi.org/10.1186/1471-2369-6-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1164417/
https://www.ncbi.nlm.nih.gov/pubmed/15910687
http://dx.doi.org/10.1186/1471-2369-6-5

Ejemplares similares